Exocytotic membrane fusion as studied in toxin-permeabilized cells.
Ahnert-Hilger
G
G
Abteilung Gastroenterologie, Klinikum Steglitz, Freien Universität Berlin, Germany.
Stecher
B
B
Beyer
C
C
Gratzl
M
M
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000313:Adrenal Medulla / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D001426:Bacterial Proteins; D002118:Calcium / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D002463:Cell Membrane Permeability; D002478:Cells, Cultured; D004298:Dopamine / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D005089:Exocytosis / Q000187:drug effects; D006461:Hemolysis; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008561:Membrane Fusion / Q000187:drug effects; D016716:PC12 Cells; D011817:Rabbits; D013211:Staphylococcus aureus; D013301:Streptolysins / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000633:toxicity*
D001426:Bacterial Proteins; D002395:Catecholamines; D013301:Streptolysins; C025964:streptolysin O; D015102:3,4-Dihydroxyphenylacetic Acid; D010738:Type C Phospholipases; D008274:Magnesium; D002118:Calcium; D004298:Dopamine